Mobilising the NHS’s hidden army
Interim report of HSJ and Serco’s Inquiry into Maximising the Contribution of Non-Clinical NHS Staff
- 1
- 2
- 3
- 4
- Currently reading
Watch: Why we are holding an inquiry on the non-clinical workforce
- 6
- 7
Mobilising the NHS’s hidden army
Interim report of HSJ and Serco’s Inquiry into Maximising the Contribution of Non-Clinical NHS Staff
- 1
- 2
- 3
- 4
- Currently reading
Watch: Why we are holding an inquiry on the non-clinical workforce
- 6
- 7
Related video
Watch: Why we are holding an inquiry on the non-clinical workforce
The non-clinical NHS workforce is often ignored or even reviled, yet it is essential its role in the future success of the service is recognised. This video introduces the HSJ/Serco Inquiry on Maximising the Contribution of NHS Non-Clinical Staff.
Latest video
Related articles
-
HSJ Knowledge
Hospital set to turn 'patient journey' theory into practice
Daloni Carlisle explains how a training programme will demonstrate to Serco facilities management staff the impact their work has on those in their hospital’s care
-
CommentMobilising our ‘Hidden Army’ for better environments, value and care
Evidence shows that happier patients get better more quickly – and that supported staff make fewer mistakes, writes Ian Crichton
-
NewsInquiry calls for an end to 'divisive' workforce hierarchy
The “second-class citizen status” of NHS staff who do not have clinical roles must be addressed urgently, an HSJ inquiry has concluded.
More from Interactive
-
HSJ InteractiveWATCH: How clinical trials and research can reshape cancer patient experience
Welcome to the latest in HSJ’s series of videos, created in collaboration with AstraZeneca for Cancer: Project Zero.
-
HSJ InteractiveWATCH: How to redesign cancer care to address inequity
Welcome to the latest in HSJ’s series of videos, created in collaboration with AstraZeneca for Cancer: Project Zero.
-
HSJ InteractiveWATCH: AI – The new ally in fighting cancer
Welcome to the second video in our series, created in collaboration with AstraZeneca for Cancer: Project Zero.
No comments yet